2019 AACR Annual Meeting Minisymposia Chairpersons. Biomarkers for Early Detection and Biologic Assessment of Cancer

Conference Program. Genomic heterogeneity in localized lung cancer Andrew Futreal, The University of Texas MD Anderson Cancer Center, Houston, TX

NOTE: Saturday, February 7 1:00 p.m.-3:00 p.m. Session A1: Cancer Genomics and Epigenomics Session Chairperson: Levi A. Garraway, Dana-Farber Cancer Institute, Boston, MA Genomic heterogeneity in localized

8:30-9:00 Increased dependence on glutamine in PTEN-deficient breast cancer Ramon E. Parsons, Icahn School of Medicine at Mount Sinai, New York, NY

CONFERENCE PROGRAM SATURDAY, OCTOBER 7 3:00 p.m.-7:00 p.m. Salon 3 of the Terrace Welcome and Keynote Lectures 6:00 p.m.-7:30 p.m. Session Chair: Ramon E. Parsons, Icahn School of Medicine at Mount Sinai,

The National Cancer Institute Cancer Centers Program. The Cancer Centers Program of the National Cancer Institute (NCI) supports major

CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s The National Cancer Institute

Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications

An AACR Special Conference on October 12-15, 2011 The Fairmont San Francisco San Francisco, CA Wednesday, October 12 7:00 p.m.-8:00 p.m. Opening Keynote Address Chairperson: Jeffrey M. Rosen, Baylor College

Welcome from the chairpersons Manuel Hidalgo, Beth Israel Deaconess Medical Center, Boston, MA

Thursday, May 12, 2016 6:00 p.m.-7:30 p.m. Opening Plenary Session Welcome from the chairpersons Manuel Hidalgo, Beth Israel Deaconess Medical Center, Boston, MA Opening remarks from the lead supporters

Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406)

Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406) ASCO Annual Meeting 2017 Randomized trial of irinotecan and cetuximab with

Molecularly Targeted Therapies: Mechanisms of Resistance

An AACR Special Conference on Molecularly Targeted Therapies: Mechanisms of Resistance May 9-12, 2012 Westin San Diego San Diego, CA Wednesday, May 9 7:00 p.m.-8:00 p.m. Opening Keynote Session BRAF and

Madrid March Manuel Hidalgo. Alberto Bardelli. Lillian Siu. Josep Tabernero. Application deadline February 23 rd

Spanish National Cancer Research Centre CNIO Frontiers Meetings 2015 Madrid 22 25 March 2015 New Trends in Anticancer Drug Development Application deadline February 23 rd Organisers Manuel Hidalgo Alberto

PROGRAM. Educational Session: Genomics 15:00-17:00 Session Chair: Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada

Thursday, May 4 Educational Session: Genomics 15:00-17:00 Session Chair: Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada Molecular Tumor Board - Case Presentation Lillian L. Siu, Patricio

C/PG2 Specialty Desc. C/PG2 Inst Name. Emory Univ SOM-GA. Child Neurology. Massachuset ts Gen Hosp North Shore Med Ctr/Salem Hosp-MA Orange Park

Inst City e e Emory Univ SOM-GA Anesthesiology ATLANTA GA A Anesthesiology Ctr- Anesthesiology BOSTON C Anesthesiology Ctr- Anesthesiology BOSTON C Anesthesiology UC San Francisco-CA Anesthesiology SAN

2014 Coffey - Holden Prostate Cancer Academy Meeting

2014 Coffey - Holden Prostate Cancer Academy Meeting Beyond immune checkpoint blockade: New Approaches to targeting Host Tumor Interactions in Prostate Cancer June 26-29, 2014 Estancia Hotel La Jolla,

Confronting the Complexity of Cancer

AACR-NCI Conference on Systems Biology February 27-March 2, 2011 Hyatt Regency La Jolla, San Diego, CA Sunday, February 27 6:00 p.m. - 7:00 p.m. Keynote Session Use of bionetworks to build better maps

6:00 p.m.-8:00 p.m. OPENING KEYNOTE ADDRESSES AND SPECIAL LECTURE Salons EF

Sunday, October 1 6:00 p.m.-8:00 p.m. OPENING KEYNOTE ADDRESSES AND SPECIAL LECTURE 6:00 p.m.-6:45 p.m. Principles of response and resistance to immunotherapy Levi A. Garraway, Eli Lilly and Company, Indianapolis,

Overall Survival (OS) Analysis From an Expanded Access Program (EAP) of Nivolumab (NIVO) in Combination with Ipilimumab (IPI) in Patients with Advanced Melanoma (MEL) David Hogg, Paul B. Chapman, 2 Mario

AGENDA: FEBRUARY 22, 2018 INTRODUCTION

FDA-AACR-ASTRO Clinical Development of Drug-Radiotherapy Combinations Workshop with support from Cancer Research UK Combinations Alliance February 22-23, 2018 Bethesda, MD Purpose: There is great interest

No Other Company Discloses Higher Transplant Survival Rate. Infusions For Emerging Treatments. Date of Use. Recipient Age (yrs)

Units Used In Transplants/Infusions No Other Company Discloses Higher Transplant Survival Rate Family Banking Provides Exclusive Access To Emerging Treatments With Your Own Cells 175 85% Type 1 Diabetes

Volunteering in Oklahoma City, OK

6/17/2010 Oklahoma City Profile - Volunteering in information on volunteering and civic engagement Volunteering in Oklahoma City, OK Statistics for this area were collected within the Oklahoma City Metropolitan

State Cd. PG1 Inst Name. Madigan Army Med Ctr

Specialty Inst City Inst City Specialty Anesthesiology Anesthesiology Anesthesiology Anesthesiology Anesthesiology Anesthesiology Anesthesiology/ UC San Francisco-CA Critical Care FRANCISCO CA C Walter

Preventing BRCA-related cancer: A think tank for innovative strategies, milestone objectives and research priorities

BANBURY CENTER REPORTS Preventing BRCA-related cancer: A think tank for innovative strategies, milestone objectives and research priorities Banbury Center, Cold Spring Harbor Laboratory, Cold Spring Harbor,

6:00 p.m.-7:00 p.m. Opening Keynote Address Salons EF

THURSDAY, OCTOBER 20 6:00 p.m.-7:00 p.m. Opening Keynote Address 6:00 p.m.-7:00 p.m. Title to be announced Tyler Jacks, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 7:00

Progr am Code Specialty. Preliminary Institution. Emory Univ SOM-GA. Child Neurology

City State Emory Univ SOM-GA Anesthesiology ATLANTA GA A Anesthesiology Ctr- Anesthesiology BOSTON C Anesthesiology Ctr- Anesthesiology BOSTON C Anesthesiology UC San Francisco-CA Anesthesiology SAN FRANCISCO

Conference Program. ATRX mutations in human carcinogenesis Nickolas E. Papadopoulos, Johns Hopkins Medical Institutes, Baltimore, MD

Conference Program Wednesday, June 19 7:00 p.m.-8:30p.m. Keynote Talks Transcriptional and epigenetic control of oncogenes Richard A. Young, MIT Whitehead Institute for Biomedical Research, Cambridge,

Plenary Session 1: Genomics Session Chair: David Malkin, The Hospital for Sick Children, Toronto, Ontario, Canada 8:00 a.m. 10:00 a.m.

AACR Special Conference on Advances in Sarcomas: From Basic Science to Clinical Translation May 16 19, 2017 Hilton Philadelphia at Penn's Landing Philadelphia, Pennsylvania Irene L. Andrulis, University

Conference at a Glance

Conference at a Glance MONDAY, NOVEMBER 14 1:00pm 1:15pm 1:15pm 4:45pm 5:00pm 7:00pm Conference Opening and Welcome Opening Plenary Session: Energy Balance, Obesity and Physical Activity Emerging Concepts

Day 0 Sunday, July 8: Arrivals. Day 1 Monday, July 9: Introduction, Fundamentals, and Germline Variation. *As of 6/29/18

AACR Integrative Molecular Epidemiology Workshop: Bridging Cancer Biology and Precision Medicine July 9-13, 2018 (*arrival July 8) Westin Copley Place, Boston Boston, Massachusetts *As of 6/29/18 Director:

11th AACR JCA Joint Conference on Breakthroughs in Cancer Research:Biology to Precision Medicine

11th AACR JCA Joint Conference on Breakthroughs in Cancer Research:Biology to Precision Medicine Friday, Feb. 8 Saturday, Feb. 9 Sunday, Feb. 10 Monday, Feb. 11 Tuesday, Feb. 12 18:30 20:00 Welcome and

7:00 p.m.-7:15 p.m. Welcome Frank McCormick, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

SUNDAY, DECEMBER 9 7:00 p.m.-8:00 p.m. WELCOME AND KEYNOTE ADDRESS 7:00 p.m.-7:15 p.m. Welcome Frank McCormick, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 7:15 p.m.-8:00 p.m.

CLINICAL PATHWAY TRACK AGENDA TUESDAY, AUGUST 23, 2016

CLINICAL PATHWAY TRACK AGENDA TUESDAY, AUGUST 23, 2016 MORNING PLENARY LECTURES: LIBERTY BALLROOM (M4) 9:00 9:15 AM Welcome and Introductions Conference Co-Chairs: Laura W. Cheever, MD, ScM; Michael S.

Conference Program. Fibroblast heterogeneity in skin tumor stroma Fiona M. Watt, King s College London, United Kingdom

Conference Program THURSDAY, JANUARY 7 6:30 p.m.-7:30 p.m. Welcoming Remarks and Opening Keynote Session Session Chairperson: Raghu Kalluri, The University of Texas MD Anderson Cancer Center, Immune checkpoint

8 th InterAmerican Oncology Conference 'Current Status and Future of Anti-Cancer Targeted Therapies' October 17-18, 2019 Buenos Aires, Argentina

FIRST ANNOUNCEMENT 8 th InterAmerican Oncology Conference 'Current Status and Future of Anti-Cancer Targeted Therapies' October 17-18, 2019 Buenos Aires, Argentina The 8 th Conference of IAOC "Current

Plenary Session 1: Genomics Session Chair: David Malkin, The Hospital for Sick Children, Toronto, Ontario, Canada 8:00 a.m. 10:00 a.m.

AACR Special Conference on Advances in Sarcomas: From Basic Science to Clinical Translation May 16 19, 2017 Hilton Philadelphia at Penn's Landing Philadelphia, Pennsylvania Irene L. Andrulis, University

February 9, The Vice President Old Executive Office Building Washington, DC Dear Mr. Vice President:

February 9, 2016 The Vice President Old Executive Office Building Washington, DC 20501 Dear Mr. Vice President: As the nation s leading organizations focused on promoting cancer research and prevention,

Conference Program. All sessions will take place in the Regency Ballroom unless otherwise noted.

Conference Program All sessions will take place in the Regency Ballroom unless otherwise noted. Monday, June 18 7:30 p.m.-9:00 p.m. Keynote Presentations and Discussion: Pancreatic Cancer 2012 Do We Have

DCIS: Margins and the USC/VNPI

DCIS: Margins and the USC/VNPI Van Nuys USC Hoag Melvin J. Silverstein, M.D Gross Endowed Chair in Oncoplastic Surgery Director, Hoag Breast Program Newport Beach, CA Clinical Professor of Surgery Keck

Bone and Skeletal Muscle Interactions

ASBMR Topical Meeting: Bone and Skeletal Muscle Interactions July 17 18, 2012 Kansas City, Missouri, USA Pre-Meeting Workshop July 16, 2012 Register now! ASBMR Topical Meeting: Bone and Skeletal Muscle

7:00 a.m. 8:00 a.m. Breakfast East Foyer, Marvin Gardens Lobby & Marvin Gardens Patio

Saturday, December 2 5:00 p.m. 6:00 p.m. Welcome and Opening Keynote The landscape of alterations in metastatic prostate cancer Arul M. Chinnaiyan, University of Michigan, Ann Arbor, MI 6:00 p.m. 8:00

Hematologic Malignancies: Translating Discoveries to Novel Therapies

Hematologic Malignancies: Translating Discoveries to Novel Therapies May 6-9, 2017 Westin Boston Waterfront Boston, Massachusetts Saturday, May 6 Plenary Session 1: Initiating and Stem Cells in Hematologic

Conference Program. micrornas and their regulatory effects David P. Bartel, MIT Whitehead Institute for Biomedical Research, Cambridge, MA

Conference Program Friday, December 4 5:30 p.m.-7:30 p.m. Plenary Session 1: Noncoding RNA Functions Session Chairperson: Joshua Mendell, UT Southwestern Medical Center, Dallas, TX Divergent transcription

Emerging Data on the Role of Wnt Biology in Cancer

MEETING AGENDA Emerging Data on the Role of Wnt Biology in Cancer The Banbury Center, Cold Spring Harbor Laboratory, New York, USA October 7-10, 2018 This meeting was funded by Leap Therapeutics Lead Organizers:

2015 Coffey - Holden Prostate Cancer Academy Meeting. Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer

2015 Coffey - Holden Prostate Cancer Academy Meeting Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer June 25-28, 2015 Estancia Hotel La Jolla, CA Program Organizing Committee:

Course Organizers: Neal Copeland, Ph.D., The Houston Methodist Research Institute Nancy Jenkins, Ph.D., The Houston Methodist Research Institute

Saturday, August 20 25 th ANNUAL SHORT COURSE ON EXPERIMENTAL MODELS OF HUMAN CANCER August 20-28, 2016 Course Organizers: Neal Copeland, Ph.D., The Houston Methodist Research Institute Nancy Jenkins,

8:30 a.m.-10:00 a.m. PLENARY SESSION 1: BIOLOGY OF THE PI3K/MTOR PATHWAY Harbor Ballroom II and III

FRIDAY, NOVEMBER 30 6:00 p.m.-7:00 p.m. OPENING KEYNOTE SESSION Welcome remarks and keynote introduction Lewis C. Cantley, Cornell Medical College, New York-Presbyterian Hospital, New York, NY PI3Kinase

HIV/AIDS and other Sexually Transmitted Diseases (STDs) in the Southern Region of the United States: Epidemiological Overview

HIV/AIDS and other Sexually Transmitted Diseases (STDs) in the Southern Region of the United States: Epidemiological Overview Prepared by The Henry J. Kaiser Family Foundation for Southern States Summit

Hematologic Malignancies: Translating Discoveries to Novel Therapies

Hematologic Malignancies: Translating Discoveries to Novel Therapies May 6-9, 2017 Westin Boston Waterfront Boston, Massachusetts Saturday, May 6 Plenary Session 1: Initiating and Stem Cells in Hematologic

CONFERENCE PROGRAM TUESDAY, FEBRUARY 16 WEDNESDAY, FEBRUARY 17. 5:00 p.m.-7:30 p.m. Welcome and Keynote Lectures Monarchy Ballroom

CONFERENCE PROGRAM TUESDAY, FEBRUARY 16 5:00 p.m.-7:30 p.m. Welcome and Keynote Lectures Session Chairpersons: Tetsuo Noda, Japanese Foundation for Cancer Research Cancer Institute, Tokyo, Japan, and Frank

Conference Program and Schedule

Wednesday, September 14 6:00 p.m.-7:00 p.m. Keynote Lecture Opening remarks Conference Chairperson: Elizabeth H. Blackburn, University of California, San Francisco, CA Building molecules to guide anticancer

CAPE FEAR VALLEY PHYSICIAN REFERRAL DIRECTORY

CAPE FEAR VALLEY PHYSICIAN REFERRAL DIRECTORY 2 0 0 6-2 0 0 7 Orthopaedics Christopher J. Barnes, MD Ohio State University College of Medicine, Columbus, OH Duke University Medical Center, Durham, NC Southern

Immunotherapy Approaches in Lymphoma

Immunotherapy Approaches in Lymphoma John Kuruvilla MD FRCPC 1 Disclosures for John Kuruvilla MD Research Support Employee Leukemia and Lymphoma Society US, Rasch Foundation Roche, N/A Consultant Abbvie,

Chapter Two Incidence & prevalence

Chapter Two Incidence & prevalence Science is the observation of things possible, whether present or past. Prescience is the knowledge of things which may come to pass, though but slowly. LEONARDO da Vinci

2012 International Nanny Association Salary and Benefits Survey Information in this report is based on the year 2011

2012 International Nanny Association Salary and Benefits Survey Information in this report is based on the year 2011 Six hundred seventy-three (673) in-home child care providers responded to this survey.

2006 FASEB Summer Research Conferences FASEB Summer Research Conference in Transplant Immunology June 3-8, 2006 Snowmass Village, Colorado

3/6/06 2006 FASEB Summer Research Conferences FASEB Summer Research Conference in Transplant Immunology June 3-8, 2006 Snowmass Village, Colorado Co-organizers: Fadi G. Lakkis, MD University of Pittsburgh

DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Targeted Cancer Therapy

DFG Hinterzartener Kreis für Krebsforschung From Molecular Mechanisms to Targeted Cancer Therapy April 26-29, 2012 Villa La Collina Cadenabbia (Co), Italy Program Committee Cathrin Brisken, Lausanne (Chair)

PACGENE. A Research Project funded by the National Cancer Institute. Not for Patient Use (R01 CA 97075)

Not for Patient Use PACGENE A Research Project funded by the National Cancer Institute (R01 CA 97075) Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE Consortium) Tackling an important problem.

Effectiveness and Costs of Osteoporosis Screening and Hormone Replacement Therapy, Vol. I: Cost-Effectiveness Analysis.

Effectiveness and Costs of Osteoporosis Screening and Hormone Replacement Therapy, Vol. I: Cost-Effectiveness Analysis August 1995 OTA-BP-H-160 GPO stock #052-003-01423-8 Recommended Citation: U.S. Congress,

An AACR Special Conference on Tumor Metastasis. November 30- December 3, 2015 Hyatt Regency Austin Austin, Texas. Conference Program

Monday, November 30 Conference Program 7:00 p.m.-8:00 p.m. Welcome and Keynote Address Welcome Remarks Bruce R. Zetter, Boston Children s Hospital, Boston, MA Melody A. Swartz, University of Chicago, Chicago,

SESSION 1: IMMUNE CHECKPOINTS: MECHANISMS AND THERAPEUTIC OPPORTUNITIES Grand Ballroom I/II

THURSDAY, SEPTEMBER 27 1200-1800 REGISTRATION Ballroom Foyer 1330-1430 WELCOME AND OPENING KEYNOTE LECTURE 1330-1340 Welcome from Scientific Committee Cochairs Carlos L. Arteaga, UT Southwestern Simmons

Repurposed RET Inhibitors : poor RET coverage in humans MKI Approved Dose Toxicities

LOXO-292, a Potent, Highly Selective RET Inhibitor, in Multi-Kinase Inhibitor-Resistant RET Fusion-Positive Lung Cancer Patients with and without Brain Metastases Vamsidhar Velcheti 1, Todd Bauer 2, Vivek

An AACR Special Conference Advances in Modeling Cancer in Mice: Technology, Biology, and Beyond

An AACR Special Conference Advances in Modeling Cancer in Mice: Technology, Biology, and Beyond September 24-27, 2017 Disney s Boardwalk Inn Orlando, Florida Sunday, September 24 Opening Keynote Session

Frontiers in PREVENTION. Research November 7-10, 2010 Pennsylvania Convention Center Philadelphia, PA

N I N T H A N N UA L A A C R I N T E R N AT I O N A L CO N F E R E N C E Frontiers in CANCER PREVENTION PROGRAM AND PROCEEDINGS November 7-10, 2010 Pennsylvania Convention Center Philadelphia, PA Continuing

JOINT STATEMENT BY MEMBERS OF THE NATIONAL COMPREHENSIVE CANCER NETWORK PROSTATE CANCER GUIDELINES PANEL

JOINT STATEMENT BY MEMBERS OF THE NATIONAL COMPREHENSIVE CANCER NETWORK PROSTATE CANCER GUIDELINES PANEL We represent 23 of our nation s leading cancer hospitals on the National Comprehensive Cancer Network

6:00 p.m.-6:10 p.m. Welcome from Cochairs Manuel Hidalgo, Beth Israel Deaconess Medical Center, Boston, MA

CONFERENCE PROGRAM FRIDAY, SEPTEMBER 21 3:00 p.m.-7:00 p.m. REGISTRATION 6:00 p.m.-8:10 p.m. WELCOME AND KEYNOTE LECTURES Session Chair: Manuel Hidalgo, Beth Israel Deaconess Medical Center, Boston, MA

2013 PROUTS NECK 2.0 MEETING ON PROSTATE CANCER. Beyond AR: New Approaches to Treating Metastatic Prostate Cancer

2013 PROUTS NECK 2.0 MEETING ON PROSTATE CANCER Beyond AR: New Approaches to Treating Metastatic Prostate Cancer June 20-23, 2013 Hyatt Regency Lake Tahoe, Nevada Program Committee Ken Pienta, M.D. Chair

YOUR DONATIONS MAKING A DIFFERENCE

YOUR DONATIONS MAKING A DIFFERENCE Grant 2013 2013 $20,000 David Langenau, M.D. 2013 $20,000 Garrett M. Brodeur, M.D. 2013 $20,000 Loren Walensky, M.D., Ph.D. Massachusetts General Hospital, Boston, MA

Immunoreceptors and Immunotherapy

Immunoreceptors and Immunotherapy June 10-15, 2018 Snowmass, Colorado Co-Organizers: E. Sally Ward Texas A&M University Health Science Center Texas, USA Stephen A. Beers University of Southampton Southampton,

Inflammation and Lung Cancer

Inflammation and Lung Cancer Steven M. Dubinett Editor Inflammation and Lung Cancer 1 3 Editor Steven M. Dubinett David Geffen School of Medicine at UCLA Los Angeles California USA ISBN 978-1-4939-2723-4

Staying on top of the current research landscape with InCites Benchmarking & Analytics: An immuno-oncology case study

Staying on top of the current research landscape with InCites Benchmarking & Analytics: An immuno-oncology case study SLA Annual Conference Biomedical & Life Sciences Division Breakfast June 2017 Amy Braden,

THE 2016 DENTAL MEETINGS AND EXHIBITS CALENDAR

HEADLINE 2016 DENTAL MEETINGS AND EXHIBITS CALENDAR The 151st Midwinter Meeting: Three Days of Dental Excellence Chicago Dental Society Chicago, Illinois February 25 27 cds.org/mwm ADA 2016 Annual Meeting

Registration Continental Breakfast. Histone Modifications and Cancer- Part 1

Miami Epigenetics & Cancer Symposium Sunday, November 27 Tuesday, November 29, 2016 Ritz-Carlton, Miami Beach Conference Room: Collins for the Office SPEAKERS PROGRAM Sunday, November 27, 2016 Speakers

Peter P. Yu (President of American Society of Clinical Oncology, ASCO) Collaboration between ASCO and JSCO: Future Perspective

第 53 回日本癌治療学会学術集会 ASCO, ESMO, ECCO からの招聘演者と講演予定 Peter P. Yu (President of American Society of Clinical Oncology, ASCO) Collaboration between ASCO and JSCO: Future Perspective Ralf A. Stahel (President

Current Research Grants

2016 Current Research Grants Institutions Albert Einstein College of Medicine, NY Brigham and Women s Hospital, MA Colorado State University, CO Dana-Farber Cancer Institute, MA Georgetown University,

Dear Speaker Ryan, Minority Leader Pelosi, Chairman Frelinghuysen, and Ranking Member Lowey:

February 23, 2018 Dear Speaker Ryan, Minority Leader Pelosi, Chairman Frelinghuysen, and Ranking Member Lowey: On behalf of the undersigned organizations we write to urge you to include an increase of

ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: September 30, ClinicalTrials.gov ID: NCT

ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: September 30, 2013 ClinicalTrials.gov ID: NCT00758043 Study Identification Unique Protocol ID: VX08-950-111 Brief

11th AACR JCA Joint Conference on Breakthroughs in Cancer Research:Biology to Precision Medicine

11th AACR JCA Joint Conference on Breakthroughs in Cancer Research:Biology to Precision Medicine Friday, Feb. 8 Saturday, Feb. 9 Sunday, Feb. 10 Monday, Feb. 11 Tuesday, Feb. 12 18:30 20:00 Welcome and

WELCOME REMARKS AND OPENING KEYNOTE SESSION

Monday, January 8 6:00 p.m. 8:00 p.m. WELCOME REMARKS AND OPENING KEYNOTE SESSION Fred Hirsch, CEO, IASLC 6:10 p.m. 6:40 p.m. Checkpoint blockade: The good, bad, and the ugly Matthew D. Hellmann, Memorial

2010 International Nanny Association Salary and Benefits Survey Information in this report is based on the year About Survey Respondents

2010 International Nanny Association Salary and Benefits Survey Information in this report is based on the year 2009 Five hundred and eighty-five (585) in-home child care providers responded to this survey.

Team Teaching: A Multidisciplinary Approach To Breast Imaging Education For Medical Students

Team Teaching: A Multidisciplinary Approach To Breast Imaging Education For Medical Students Authors Robert Gray 1, Maria Castaldi 2, Miriam David 2 1 Philadelphia College of Osteopathic Medicine Georgia

SETPOINT2 Quarterly Newsletter July 5, 2017

SETPOINT2 Quarterly Newsletter July 5, 2017 We are very pleased to introduce the SETPOINT2 newsletter. SETPOINT2 is a research study involving people with stroke and respiratory failure (breathing problems)

Full Schedule. Sunday. Neural Circuits Controlling Sexual Behavior. 3:00 pm Check-in. 6:00 pm Reception. 7:00 pm Dinner

Full Schedule Sunday 3:00 pm Check-in 6:00 pm Reception 7:00 pm Dinner 8:00 pm Session 1: Sex circuits in the worm Chair: Nirao Shah 8:00 pm Doug Portman, University of Rochester Sex-dependent modification

2012 Medicaid and Partnership Chart

2012 Medicaid and Chart or Alabama $525,000.00 $4,800.00 Minimum: 25,000.00 Alaska $525,000.00 Depends on area of state; Minimum: $113,640 $10,000 in Anchorage $1,656 Minimum:$1838.75 Maximum:$2,841 Minimum:

ASA Anesthesiology 2012 Walter E. Washington Convention Center Washington D.C. October 13 17, 2012

ASA Anesthesiology 2012 Walter E. Washington Convention Center Washington D.C. October 13 17, 2012 Educational Offerings on Quality Improvement and Registries For More Information and Registration, go

The TargetCancer Think Tank on Cholangiocarcinoma Organized by Nabeel Bardeesy, PhD and Jay Bradner, M.D. November 16, :30 a.m. 1:30 p.m.

The TargetCancer Think Tank on Cholangiocarcinoma Organized by Nabeel Bardeesy, PhD and Jay Bradner, M.D. November 16, 2012 7:30 a.m. 1:30 p.m. McGladrey 80 City Square, at the Charlestown Navy Yard Boston,

Session Chair: Lynette Denny, University of Cape Town, Cape Town, South Africa

WEDNESDAY, JANUARY 18 Concurrent Sessions 1-2 15:00-16:30 Cervical Cancer Ballroom East Session Chair: Lynette Denny, University of Cape Town, Cape Town, South Africa Progress in scaling up cervical cancer

The Role of Nonpharmacological Approaches to Pain Management: A Workshop

The Role of Nonpharmacological Approaches to Pain Management: A Workshop December 4 5, 2018 National Academy of Sciences Building 2101 Constitution Avenue, NW Washington, DC Background: Pain is a leading

Invited Journal: Nature Medicine. Sponsors: Thermo Fisher Novocure Merck. Venue: Spanish National Cancer Research Centre CNIO Auditorium Madrid, Spain

CNIO Frontiers Meetings Primary and Secondary Brain Tumors 19th-22nd February 2017 Organisers: Richard Gilbertson CRUK Cambridge Institute, UK Michael Weller University Hospital Zurich, Switzerland Massimo

SUPPORTIVE CARE IN CANCER THERAPY

SUPPORTIVE CARE IN CANCER THERAPY For other titles published in this series, go to www.springer.com/series/7625 SUPPORTIVE CARE IN CANCER THERAPY Edited by DAVID S. ETTINGER, MD The Sidney Kimmel Comprehensive

Session Chair: David Malkin, The Hospital for Sick Children, Toronto, ON, Canada

TUESDAY, MAY 16 5:00 p.m. 6:00 p.m. Welcome and Opening Keynote 6:00 p.m. 8:30 p.m. Welcome Reception SWI/SNF (BAF) complex mutations in cancer: Mechanisms and vulnerabilities Charles W. M. Roberts, St.

4 TH International LFS Association Symposium

4 TH International LFS Association Symposium hosted by The Hospital for Sick Children and in partnership with the LiFE Consortium April 25-29 TH, 2018 Toronto, Ontario Canada CONFERENCE AGENDA WEDNESDAY,

Where Debate & Discussion Translate to Breakthroughs. Now Offering 2 Locations. Greatdebatesinhema.com

Part of the Oncology Learning Network Now Offering 2 Locations March 22 23, 2019 Marina del Rey Marriott Marina del Rey, California April 5 6, 2019 Crowne Plaza Times Square Manhattan, New York Where Debate

San Antonio Breast Cancer Symposium December 5-9, 2017

Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2-SN-38 Antibody-Drug Conjugate, as 3rd-line Therapeutic Option for Patients With Relapsed/Refractory Metastatic Triple-Negative Breast Cancer (mtnbc): Efficacy

B&T Format. New Measures. Better health care. Better choices. Better health.

1100 13th Street NW, Third Floor Washington, DC 20005 phone 202.955.3500 fax 202.955.3599 www.ncqa.org TO: Interested Organizations FROM: Patrick Dahill, Assistant Vice President, Policy DATE: February

Walk. Give. To help them live. November 23

PROJECT 13 PARTNERSHIP: St. Jude Children s Research Hospital 2013 Give thanks. Walk. Toolkit Walk. Give. To help them live. November 23 Delta Sigma Theta Sorority, Inc. is proud to continue our support

Clinical Activity and Safety of Anti-PD-1 (BMS , MDX-1106) in Patients with Advanced Non-Small-Cell Lung Cancer

Clinical Activity and Safety of Anti-PD-1 (BMS-936558, MDX-1106) in Patients with Advanced Non-Small-Cell Lung Cancer J.R. Brahmer, 1 L. Horn, 2 S.J. Antonia, 3 D. Spigel, 4 L. Gandhi, 5 L.V. Sequist,

Conference Program. New assays, old specimens: Multiplexing for plasma and urine Patrick M. Sluss, Massachusetts General Hospital, Boston, MA

Conference Program Sunday, November 11 1:30 p.m.-3:00 p.m. Educational Session 1: Digging Deeper: New Approaches to Assaying Biospecimens in Epidemiology Chairperson: David G. Cox, Cancer Research Center

Immune Checkpoints in the Tumor Environment:

Immune Checkpoints in the Tumor Environment: Novel Targets and the Clinical Promise of Combined Immunotherapies Monday, 28 October 2013 07.00 08.00 (AM) Parkside Ballroom B, Convention Centre Level 1 Phosphatidylserine

Charisse Litchman Editor. Desmoid Tumors

Desmoid Tumors Charisse Litchman Editor Desmoid Tumors 1 3 Editor Dr. Charisse Litchman Department of Neurology, The Stamford Hospital, Stamford, CT 06904 Assistant Clinical Professor, Department of Neurology,

The Heart Institute Tenth Anniversary Update. October 23, 2017

The Heart Institute Tenth Anniversary Update October 23, 2017 Organizational Structure Medicine Surgery Imaging Anesthesiology Pediatrics Basic Biomedical Sciences BEFORE AFTER * Services provided by contract

Determinants of response and resistance in drug discovery and development Tona M. Gilmer

An AACR Special Conference on Translation of the Cancer Genome: Scientific, Clinical, and Operational Challenges October 15-18, 2011 Hyatt Regency San Francisco San Francisco, CA Saturday, October 15 1:00

AACR Special Conference: Tumor Immunology and Immunotherapy November 27-30, 2018 Loews Miami Beach Hotel Miami Beach, Florida

CONFERENCE PROGRAM Tuesday, November 27 5:00 p.m.-7:00 p.m. Opening Keynote Lectures 5:00 p.m.-6:00 p.m. Turning the heat up on pancreatic cancer: Lessons on overcoming a cold immunologic microenvironment

NCQA did not add new measures to Accreditation 2017 scoring.

2017 Accreditation Benchmarks and Thresholds 1 TO: Interested Organizations FROM: Patrick Dahill, Assistant Vice President, Policy DATE: August 2, 2017 RE: 2017 Accreditation Benchmarks and Thresholds